secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK:        0001062822
Form:       8-K
Filed at:   2023-07-24T23:59:59+00:00
Accession:  0001062822-23-000030
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Frank P. Palantoni resigns from Lexicon board effective July 27, 2023
------------------------------------------------------------------------------

- Frank P. Palantoni notified Lexicon of his resignation from the board on July 18, 2023.
- Resignation effective July 27, 2023; no disagreement with company operations or policies.
- Mr. Palantoni's departure is not due to any dispute with Lexicon.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1062822/000106282223000030/0001062822-23-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1062822/000106282223000030/lxrx-20230718.htm
  HTML page:      https://secwatch.observer/filing/0001062822-23-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer